Media.Player

Novel Approach for Intracellular Delivery of Biomolecules

技術優勢

High efficiency (>90%) of the transfection of encapsulated SNPs No need to pre-coat substrate with biomolecules, therefore allowing multiple doses to be administered Improved delivery in difficult-to-transfect cell lines

技術應用

This platform can be applied to the delivery of assorted biomolecules including genes, proteins, RNA species, drugs and reporters Possibility to re-engineer the CDNS/SNP recognition motifs generating a robust platform

詳細技術說明

Researchers in the laboratory of Dr. Hsian-Rong Tseng at UCLA have utilized a nanowire grafted substrate for the delivery of biomolecules. The surface of the nanowire substrate has been coated with a particular molecular recognition motif, referred to as a catalytic delivery nanosubstrate (CDNS), which enables delivery of the biomolecules into the cell of interest. The binding partner of the CDNS recognition motif is coated on a supramolecular nanoparticle (SNP) that houses the biomolecule to be delivered. The CDNS serves to concentrate SNPs from the cell culture medium onto the nanosubstrate and enhances local topological interactions between the SNP and the cell to improve biomolecule delivery. Utilization of the CDNS and SNP in combination significantly increases delivery efficiency compared to just SNPs alone. This technology provides a platform for the delivery of diverse biomolecules with high efficiency in a wide range of cells that are difficult to transfect including primary cells, stem cells, neuronal cells and immune cells.

*Abstract

Researchers at UCLA have developed a nanowire-based substrate technology for the efficient delivery of biomolecules. The system has clear applications for basic biological research and potentially for the treatment of diseases.

*Applications

• This platform can be applied to the delivery of assorted biomolecules including genes, proteins, RNA species, drugs and reporters
• Possibility to re-engineer the CDNS/SNP recognition motifs generating a robust platform

*IP Issue Date

Jul 3, 2014

*Principal Investigation

Name: Kuan-Ju Chen

Department:

Name: Hsian-Rong Tseng

Department:

Name: Hao Wang

Department:

附加資料

Inventor: CHAN, Pui, Barbara | CHAN, Cheukming | SO, Kwokfai
Priority Number: WO2009006792A1
IPC Current: B01J001314 | A61K000950 | A61K000952
Assignee Applicant: The University of Hong Kong
Title: COLLAGEN-BASED MICROSPHERES AND METHODS OF PREPARATION AND USE THEREOF | MICROSPHÈRES À BASE DE COLLAGÈNE ET LEURS PROCÉDÉS DE PRÉPARATION ET UTILISATION
Usefulness: COLLAGEN-BASED MICROSPHERES AND METHODS OF PREPARATION AND USE THEREOF | MICROSPHÈRES À BASE DE COLLAGÈNE ET LEURS PROCÉDÉS DE PRÉPARATION ET UTILISATION
Summary: The method is for preparing natural extracellular matrix-based microspheres or population of microspheres for forming into structures for use in tissue engineering (claimed), and useful for drug delivery as well as cell culture i.e. three dimensional cell culture and implantation. The microspheres or microparticles can be formed into additional structures as coatings, encapsulated, or incorporated into other materials that act as binders, e.g. for use as tissue engineering matrices.
Novelty: Preparation of natural extracellular matrix-based microspheres by initiating sol-gel transition of natural extracellular matrix components, decelerating sol-gel transition, forming water-in-oil emulsion, and accelerating sol-gel transition

主要類別

生物醫學

細分類別

醫藥成分

申請號碼

20140186426

其他

State Of Development

Researchers have also been able to show that delivery efficiency is increased using the CDNS/SNP system compared to traditional methods of transfection including Lipofectamine2000, jetPEI™-RGD, and SNPs alone. Additionally, researchers have also been able to show that different biomolecules can be delivered sequentially.

Background

The delivery of biomolecules, including therapeutic drugs, genes and proteins, provides a promising vehicle for the treatment of many incurable diseases. Efficient delivery of biomolecules remains a technical challenge due to poor targeting and delivery efficiency. The use of viral-, liposome-, and nanotube-mediated techniques for the delivery of biomolecules has been hindered by their cytotoxicity, low efficiency and poor biocompatibility properties. Delivery mechanisms that utilize cell culture substrates, such as nanowire-grafted surfaces, have recently gained traction as a promising method for drug delivery. However, the use of nanowire-based delivery substrates require the cells to be pre-coated with biomolecules, preventing repeated doses or sequential combination of therapies. The invention disclosed here utilizes a novel nanowire-based delivery approach capable of achieving efficiency rates greater than 90%.

Additional Technologies by these Inventors

• Bioorthogonal Ligation Mediated Rare-Cell Capture in Microfluidic Devices

Tech ID/UC Case

22527/2011-475-0

Related Cases

2011-475-0

國家/地區

美國